BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35758394)

  • 1. Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7.
    Ebrahim T; Hadebe B; Aldous C; Tinarwo P; Nyakale N
    Medicine (Baltimore); 2022 Jun; 101(25):e29515. PubMed ID: 35758394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
    Wang ZL; Wang XF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.
    Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ
    BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
    Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
    Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.
    Ulmert D; Kaboteh R; Fox JJ; Savage C; Evans MJ; Lilja H; Abrahamsson PA; Björk T; Gerdtsson A; Bjartell A; Gjertsson P; Höglund P; Lomsky M; Ohlsson M; Richter J; Sadik M; Morris MJ; Scher HI; Sjöstrand K; Yu A; Suurküla M; Edenbrandt L; Larson SM
    Eur Urol; 2012 Jul; 62(1):78-84. PubMed ID: 22306323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer.
    Poulsen MH; Rasmussen J; Edenbrandt L; Høilund-Carlsen PF; Gerke O; Johansen A; Lund L
    BJU Int; 2016 May; 117(5):748-53. PubMed ID: 25906907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
    Wei RJ; Li TY; Yang XC; Jia N; Yang XL; Song HB
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S; Liehn JC; Desoize B; Larbre H; Deltour G; Valeyre J
    Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between low Gleason score and prostate specific antigen levels with incidence of bone metastases in prostate cancer patients: when to omit bone scans?
    Sanjaya IP; Mochtar CA; Umbas R
    Asian Pac J Cancer Prev; 2013; 14(9):4973-6. PubMed ID: 24175761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
    Akimoto S; Furuya Y; Akakura K; Shimazaki J; Ito H
    Int J Urol; 1997 Nov; 4(6):572-5. PubMed ID: 9477186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
    Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
    Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.
    Imbriaco M; Larson SM; Yeung HW; Mawlawi OR; Erdi Y; Venkatraman ES; Scher HI
    Clin Cancer Res; 1998 Jul; 4(7):1765-72. PubMed ID: 9676853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma.
    Chen Y; Lin Y; Nie P; Jiang W; Liu Y; Yuan R; Li M; Zhao S; Lin H; Li P; Zhang J; Hu Z; Xu J; Zhu X
    Med Sci Monit; 2017 Apr; 23():1768-1774. PubMed ID: 28400549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.